2011
DOI: 10.1016/j.actatropica.2011.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 31 publications
0
13
0
Order By: Relevance
“…In veterinary medicine, studies of PON1 have traditionally focused in bovine (Miyamoto et al, 2005;Turk et al, 2008), but in the last few years there has been an increased interest in other species such as cats (Tvarijonaviciute et al, 2012a,b,c), dogs (Tvarijonaviciute et al, 2012a,b,c) and horses (Turk et al, 2011). However, to date, to the best of authors' knowledge, PON1 in the porcine species only has been studied in the case of miniature pigs, using the 5-thiobutil butyrolactone (TBBL) method, in a report dealing with cardiovascular disease (De Keyzer et al, 2009).…”
Section: Introductionmentioning
confidence: 98%
“…In veterinary medicine, studies of PON1 have traditionally focused in bovine (Miyamoto et al, 2005;Turk et al, 2008), but in the last few years there has been an increased interest in other species such as cats (Tvarijonaviciute et al, 2012a,b,c), dogs (Tvarijonaviciute et al, 2012a,b,c) and horses (Turk et al, 2011). However, to date, to the best of authors' knowledge, PON1 in the porcine species only has been studied in the case of miniature pigs, using the 5-thiobutil butyrolactone (TBBL) method, in a report dealing with cardiovascular disease (De Keyzer et al, 2009).…”
Section: Introductionmentioning
confidence: 98%
“…But more recently research has been focused on other clinical aspects such as protective role in vascular disease as well as its use as biomarker of diseases involving mainly three situations: (a) oxidative stress, since PON1 protects against oxidation [8]; (b) inflammation, being considered PON1 as a negative acute phase protein [9] and (c) liver diseases, because PON1 is synthesized in this organ [10]. In veterinary medicine, studies of PON1 have been traditionally focused in bovine [11,12], however in recent years it has gained interest in other species such as dogs [13,14], cats [15] and horses [16]. …”
Section: Introductionmentioning
confidence: 99%
“…Feingold et al (1998) reported a reduced hepatic synthesis of this enzyme in hamsters during the acute phase response. Decreases have been also described in cattle (Bionaz et al, 2007), laboratory animals (Franco-Pons et al, 2008), humans (Novak et al, 2010), horses (Turk et al, 2011) and dogs (Tvarijonaviciute et al, 2012a(Tvarijonaviciute et al, , 2012b. Owing to the wide spectrum of species on which PON1 is reduced in inflammation, to study this molecule also in cats may be important.…”
Section: Introductionmentioning
confidence: 99%